Navigation Links
Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies
Date:11/9/2009

PHILADELPHIA November 9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced the availability of INTUNIV (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17. INTUNIV, a once-daily formulation of guanfacine, is the first and only nonscheduled alpha-2A receptor agonist approved for the treatment of ADHD. In clinical trials, INTUNIV provided significant efficacy across the spectrum of ADHD symptoms that can be disruptive, such as being easily distracted, interrupting others, running around excessively, arguing with adults, and losing temper.

"INTUNIV has been shown to improve a range of ADHD symptoms and provides prescribers and patients with another treatment option for this complex disorder," said Rakesh Jain, MD, MPH, Director of Psychopharmacology Research at R/D Clinical Research, Inc, in Lake Jackson, Texas. "In clinical studies, INTUNIV was shown to provide significant ADHD symptom improvement across a full day, as reported by parents at approximately 6 PM, 8 PM, and 6 AM the next morning. These findings suggest that INTUNIV may be an important treatment option for children and adolescents with ADHD who are faced with the complexities of the disorder, both at school and at home. Because of this, many clinicians such as myself, have been highly anticipating its availability."

The US Food and Drug Administration (FDA) approved INTUNIV on September 2, 2009. Once-daily INTUNIV is now available in US pharmacies in four dosage strengths (1 mg, 2 mg, 3 mg, and 4 mg) and is marketed in the United States by the existing Shire ADHD sales team of nearly 600 representatives. INTUNIV is not a controlled substance and has no known potential for abuse or dependence.

"INTUNIV is the newest ADHD treatment to receive FDA approval and the latest addit
'/>"/>

Contact: Matt Cabrey
mcabrey@shire.com
484-595-8248
Porter Novelli
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. MEDA Receives FDA Approval of New ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine
2. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
3. Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study
4. New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
5. Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
6. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
7. Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
8. Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
9. European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1
10. Once-Daily Combo Works for New HIV Patients
11. Labopharms Once-Daily Tramadol Product Launched in South Korea, Australia, Romania and Austria

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , LANSING, Mich., Nov. 20 /PRNewswire-USNe...one in seven Americans struggled to get enough foo... difficulties of older adults who are rapidly agin... the death of a spouse or divorce mean many have i...food, housing and medicine. Older women are parti...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 The Uni...em reform legislation which contains a 5% tax on c...poses. The American Academy of Facial Plastic and...ngly opposes the inclusion of this tax as it is di...s. ,, If passed into law, the tax will go int...
(Date:11/20/2009)... Jackson Healthcare® i... the national healthcare network, to deliver multi...ubstitute) assignments and permanent physician pla...(Vocus) November 20, 2009 -- Jackson Healthcare is...the national healthcare network, to deliver multis...
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-USNe...rial by Pharmaceutical Research and Manufacturer...hnson. In the editorial, Johnson makes the case fo...to supporting this historic effort. ,, Johnson ...d is real and growing and reiterates PhRMA,s pos...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 R...ch report is available in its catalogue. ,, To...w.reportlinker.com/p0164389/Toothpaste---Global-Ma...ium=pr&utm_campaign=prnewswire ,, Toothpa...l care market. The frequency of product launches i...
Breaking Medicine News(10 mins):Health News:AAFPRS Opposes the Proposed Tax on Medical Procedures 2Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 2Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 3Health News:Reportlinker Adds Toothpaste - Global Market Trends 2Health News:Reportlinker Adds Toothpaste - Global Market Trends 3Health News:Reportlinker Adds Toothpaste - Global Market Trends 4Health News:Reportlinker Adds Toothpaste - Global Market Trends 5Health News:Reportlinker Adds Toothpaste - Global Market Trends 6Health News:Reportlinker Adds Toothpaste - Global Market Trends 7Health News:Reportlinker Adds Toothpaste - Global Market Trends 8Health News:Reportlinker Adds Toothpaste - Global Market Trends 9Health News:Reportlinker Adds Toothpaste - Global Market Trends 10
...ent,government data from the Agency for Healthcare...l-service pharmacies serve a disproportionate shar...ns, public programs are not,taking full advantage ...policymakers are seeking public program savings, P...
...an assistant professor of biomedical engineering ... Technology Council as one of their 2008 Women of...h year, honors Connecticut women in eight categori...m 105 nominees. , According to Matthew Nemerson, ...
...Resource Group, the,equipment planning division of...truction), announced it has hired Ryan Frymire as ...Technology Planning, Frymire will help manage the,...eated position at Balfour Resource Group, as the c...
...o Campero and Corporacion Multi Invers...LA CITY, Feb. 25 Fundacion Ayudame a Vivir, a,Gua...for cancer treatment,of underprivileged children, ...ery. The lottery included prizes,consisting of ten...
...e Hospital,s Operations and Revenue ...25 Keane, Inc., a $1,billion-plus global services...of its clients, business and IT functions, today a...,EZ-Access Patcom and a host of new revenue cycle ...
...orporation,of America (Nasdaq: DCAI ) announced t...Carolina, has been certified and in now open and t...thern part of the state, began,construction last y...are exited to open this,newest facility, which wil...
Other Medicine News:Health News:New Government Data: Mail-Service Pharmacies Grow, But Public Programs Lag Behind 2Health News:Yale scientist honored for academic innovation and leadership 2Health News:Balfour Resource Group Announces Ryan Frymire as Director of Technology Planning 2Health News:Guatemala's Fundacion Ayudame a Vivir Fundraising Campaign Raises More Than $2.6 Million 2Health News:Keane Wins Revenue Cycle Management Implementation With Mount Sinai Hospital of Queens 2Health News:Keane Wins Revenue Cycle Management Implementation With Mount Sinai Hospital of Queens 3Health News:Dialysis Corporation of America Announces its Newest Center Opening in South Carolina 2
(Date:11/20/2009)...ass. and LONDON, Nov. 20 ...y announced that it has received 510(k) clearance ...nd CE Mark approval to market its WallFlex® F... malignant esophageal strictures (obstructions) ca...resectable esophageal cancer. ,, (Photo: htt...
(Date:11/20/2009)...n., Nov. 20 Smith &...pleased to announce the signing of a technology de...nt of Defense that may lead to the creation of a f...the treatment of the limbs of soldiers who sustain...e Advanced Research Projects Agency (DARPA), the c...
(Date:11/19/2009)... Colo., Nov. 19 In a ser...xperience, Heska Corporation (Nasdaq: HSKA ) ("He...of its new and improved website. The upgraded sit...ign and programming to align the site with the com...,, (Logo: http://www.newscom.com/cgi-bin/prnh...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Watchful Waiting Works for Older Men With Prostate Cancer 57270 1Watchful Waiting Works for Older Men With Prostate Cancer 57270 2Watchful Waiting Works for Older Men With Prostate Cancer 57270 3FDA Approves 4 Swine Flu Vaccines 57268 1FDA Approves 4 Swine Flu Vaccines 57268 2FDA Approves 4 Swine Flu Vaccines 57268 3FDA Approves 4 Swine Flu Vaccines 57268 4U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 1U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 2U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 3U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 4U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 5
...al, Inc., the largest,privately held spinal implan...the first FLEXUS(TM) Interspinous Spacers have bee...ion ("IDE") recently granted to Globus by Dr.,Dona...M) Spacer is placed with a unilateral approach bet... to the surrounding musculature,and tissue. FLEXUS...
... Clinical Trials,Bootcamp announces its inaugural ...rdinators, clinical research staff and other parti... Raton at the Boca Resort from May,14-17th, 2009. ...nitors and,other industry personnel will present i...s into a practice, as well as how to take an exist...
Other Medicine Technology:First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: